Evidence-based medicine as Bayesian decision-making

Statistics in Medicine

Volumn 19, Issue 23, 2000, Pages 3291-3305

  Ashby, Deborah ^a   Smith, Adrian F M ^b  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BAYES THEOREM; COST; DECISION MAKING; EVIDENCE BASED MEDICINE; HEALTH CARE SYSTEM; REVIEW; STATISTICS;

BAYES THEOREM; DECISION MAKING; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; MALE;

EID: 0034672540     PISSN: 02776715     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0258(20001215)19:23<3291::AID-SIM627>3.0.CO;2-T     Document Type: Review

References (55)

1. Evidence based medicine: What it is and what it isn't
2. Future prospects for evidence-based child health
3. Not playing with a full DEC: Why development and evaluation committee methods for appraising new drugs may be inadequate
4. NICE
5. Methods for the analysis of quality-of-life and survival data in health technology assessment
6. The number needed to treat: A clinically useful measure of treatment effect
7. An essay towards solving a problem in the doctrine of chances
8. Prevention of neural tube defects: Results of the Medical Research Council vitamin study
9. Quantifying the decline in the birth prevalence of neural tube defects. England and Wales
10. Using numerical results from systematic reviews in clinical practice
11. Decision analysis and clinical decisions
12. Exploratory thoughts on clinical trials with utilities
13. Some problems connected with statistical inference
14. Bayesian analysis of stress thallium-201 scintigraphy
15. Bayesian approaches to randomized trials
16. Practical reporting of Bayesian analyses of clinical trials
17. Bayesian inference for generalized linear and proportional hazards models via Gibbs sampling
18. A Bayesian approach to Weibull survival models - Application to a cancer clinical trial
19. A Bayesian analysis of the two-period crossover design for clinical trials
20. Assessing drug interactions: Tamoxifen and cyclophosphamide
21. Bayesian design and analysis of two x two factorial clinical trials
22. Bayesian subset analysis in a colorectal cancer clinical trial
23. Biostatics and Bayes
24. Bayesian epidemiology
25. Bayesian approaches to random-effects meta-analysis: A comparative study
26. Investigating underlying risk as a source of heterogeneity in meta-analysis
27. Meta-analysis for the evaluation of potential surrogate markers
28. Computation on Bayesian graphical models
29. Bayesian methods in health technology assessment: A review
30. Bayes' theorem and decision support in 'front line' clinical medicine
31. Some points on the use of 'independent Bayes' to diagnose acute abdominal pain
32. Equipoise and the ethics of randomization
33. Public health decision making: A sequential vaccine trial
34. Bayesian experimental design: A review
35. Applications of Lindley information measure to the design of clinical experiments
36. Bayesian data monitoring in clinical trials
37. A Weibull model for survival data: Using prediction to decide when to stop a clinical trial
38. Bayesian decision procedures for dose determining experiments
39. Project evaluation in drug development: A case study in collaboration
40. The statistical basis of public policy: A paradigm shift is overdue
41. Clinical significance not statistical significance: A simple Bayesian alternative to p values
42. Decision models in clinical recommendations development: The stroke prevention policy model
43. Decision analysis and the implementation of research findings
44. The stroke prevention policy model: Linking evidence and clinical decisions